MetaADEDB 2.0 @ LMMD
Acenocoumarol
(VABCILAOYCMVPS-UHFFFAOYSA-N)
Structure
SMILES
CC(=O)CC(c1c(=O)oc2c(c1O)cccc2)c1ccc(cc1)[N+](=O)[O-]
Type(s)
Approved; Investigational
ATC code(s)
B01AA07
Molecular Formula:
C19H15NO6
Molecular Weight:
353.325
Log P:
4.0410
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
113.33
CAS Number(s):
152-72-7; 70897-81-3
Synonym(s)
1.
Acenocoumarol
2.
Acenocoumarin
3.
Nicoumalone
4.
Mini-Sintrom
5.
Sinkumar
6.
Sinthrome
7.
Sintrom
8.
Syncoumar
9.
Syncumar
10.
Synthrom
11.
Mini Sintrom
12.
MiniSintrom
External Link(s)
MeSHD000074
PubChem Compound54676537
ChEBI53766
CHEMBLCHEMBL397420
DrugBankDB01418
IUPHAR/BPS Guide to PHARMACOLOGY9015
KEGGdr:D07064
Therapeutic Target DatabaseD05HFY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal symptomSIDER
2AbscessOFFSIDES
3AcanthosisOFFSIDES
4Acute Coronary SyndromeOFFSIDES
5Acute kidney injury15327563CTD
6Acute left ventricular failureOFFSIDES
7AdenocarcinomaOFFSIDES
8AgraphiaOFFSIDES
9AlopeciaSIDER
10AlveolitisOFFSIDES
11AngiodysplasiaOFFSIDES
12AngioedemaOFFSIDES
13Anogenital dysplasiaOFFSIDES
14Anoxic EncephalopathyOFFSIDES
15Anticholinergic SyndromeOFFSIDES
16Anticoagulation drug level below therapeuticCanada Vigilance: 1Canada Vigilance
17Antiviral drug level above therapeuticOFFSIDES
18AnuriaOFFSIDES
19Aortic Diseases8171941CTD
20ApathyOFFSIDES
21ArteritisOFFSIDES
22AtaxiaOFFSIDES
23Atrial Fibrillation1682588
16981216
CTD
24Atrial FlutterOFFSIDES
25AuraOFFSIDES
26Bacterial EndocarditisOFFSIDES
27Bilirubin conjugated increasedOFFSIDES
28Blood glucose decreasedOFFSIDES
29Blood lactate dehydrogenase increasedOFFSIDES
30Blood sodiumOFFSIDES
31Blood uric acidOFFSIDES
32Bone marrow depressionOFFSIDES
33BradycardiaOFFSIDES
34Brain Infarction1682588CTD
35Bronchial ObstructionOFFSIDES
36BronchopneumoniaOFFSIDES
37Cardiac enzymes increasedOFFSIDES
38Cardiac ventricular disorderOFFSIDES
39Catheter placementOFFSIDES
40Cerebral atrophyOFFSIDES
41Chemical and Drug Induced Liver Injury1479182
9499683
12743448
CTD
42Chemotherapeutic drug level increasedOFFSIDES
43CholangiolitisOFFSIDES
44Cholestasis9499683CTD
45ClumsinessOFFSIDES
46Coagulation test abnormalOFFSIDES
47Complications of transplant surgeryOFFSIDES
48ConfabulationOFFSIDES
49Corneal UlcerOFFSIDES
50Corneal abscessOFFSIDES
51Cytolytic hepatitisOFFSIDES
52DermatitisSIDER
53DiplopiaOFFSIDES
54Disseminated Intravascular Coagulation10822766CTD
55DrowsinessOFFSIDES
56Drug ineffectiveCanada Vigilance: 3Canada Vigilance
57Drug level below therapeuticOFFSIDES
58Drug toxicityOFFSIDES
59Dry skinOFFSIDES
60DuodenitisOFFSIDES
61EczemaOFFSIDES
62Embolism19225864CTD
63EndophthalmitisOFFSIDES
64EpistaxisCanada Vigilance: 1Canada Vigilance
OFFSIDES
65Erosive gastritisOFFSIDES
66Femoral Neuropathy6186784CTD
67Fluid overloadOFFSIDES
68Gamma-Glutamyltransferase IncreasedOFFSIDES
69GangreneOFFSIDES
70GastroenteritisOFFSIDES
71General physical health deteriorationOFFSIDES
72GlobulinuriaOFFSIDES
73Headache12944455CTD
74Hematoma, Subdural12944455CTD
75Hematoma6186784CTD
76Hemisensory NeglectOFFSIDES
77Hemorrhage15826524
19225864
CTD
78Hepatitis B DNA increasedOFFSIDES
79HepatosplenomegalyOFFSIDES
80HiccoughOFFSIDES
81HidradenitisOFFSIDES
82HydrothoraxOFFSIDES
83HypersensitivitySIDER
84Hypertensive heart diseaseOFFSIDES
85Hypesthesia12944455CTD
86HypokinesiaOFFSIDES
87Iatrogenic injuryOFFSIDES
88InfectionOFFSIDES
89Injection site phlebitisOFFSIDES
90Kidney FailureOFFSIDES
91Left atrial dilatationOFFSIDES
92LeukoaraiosisOFFSIDES
93Listeria encephalitisOFFSIDES
94Livedo ReticularisOFFSIDES
95LymphocytosisOFFSIDES
96MenorrhagiaSIDER
97MetrorrhagiaSIDER
98Microscopic hematuriaSIDER
99Mixed liver injuryOFFSIDES
100NauseaSIDER
101Neck Pain12944455CTD
102Necrosis15327563CTD
103NystagmusOFFSIDES
104Oral fungal infectionOFFSIDES
105Oral mucosal exfoliationOFFSIDES
106OverdoseOFFSIDES
107PROTHROMBIN TIMEOFFSIDES
108Pain6186784CTD
109PallorOFFSIDES
110ParapsoriasisOFFSIDES
111Performance status decreasedOFFSIDES
112PeritonitisOFFSIDES
113PhlebitisOFFSIDES
114PleurisyOFFSIDES
115PneumothoraxOFFSIDES
116Polymyalgia RheumaticaOFFSIDES
117Poor personal hygieneOFFSIDES
118Post procedural complicationOFFSIDES
119Product quality issueCanada Vigilance: 1Canada Vigilance
120Protein C DeficiencySIDER
121Prothrombin level decreasedOFFSIDES
122Pulmonary HypertensionOFFSIDES
123Pulmonary arterial hypertensionOFFSIDES
124RalesOFFSIDES
125Respiratory FailureOFFSIDES
126Respiratory tract irritationOFFSIDES
127Reticulocyte count increasedOFFSIDES
128Retinal exudatesOFFSIDES
129Rheumatic Heart Disease10878885CTD
130Rupture, Spontaneous8430022CTD
131ScotomaOFFSIDES
132Septic ShockOFFSIDES
133Skin necrosisSIDER
134Status EpilepticusOFFSIDES
135Sudden deathOFFSIDES
136Supraventricular tachycardiaOFFSIDES
137Terminal stateOFFSIDES
138Therapeutic response unexpectedCanada Vigilance: 1Canada Vigilance
139Therapy non-responderOFFSIDES
140Thrombocytopenia8171941CTD
141Thromboembolism8171941
18698879
19225864
CTD
142TracheobronchitisOFFSIDES
143Transaminases increasedOFFSIDES
144UlcerSIDER
145Urinary Retention12944455CTD
146UrticariaSIDER
147Vasculitis, Leukocytoclastic, Cutaneous8490477
10329927
16981216
CTD
148Venous InsufficiencyOFFSIDES
149Venous Thromboembolism12755667CTD
150Venous Thrombosis8171941
20473075
28867752
CTD
151Ventricular FibrillationOFFSIDES
152Visual disturbanceOFFSIDES
153VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.